Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055511/0606 | |
| Pages: | 7 |
| | Recorded: | 03/04/2021 | | |
| Attorney Dkt #: | 213597-0004-00-US-000005 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17052133
|
Filing Dt:
|
10/30/2020
|
|
Publication #:
|
|
Pub Dt:
|
04/29/2021
| | | | |
|
Title:
|
BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND A PD-1 ANTAGONIST
|
|
|
Assignee
|
|
|
|
|
| 6-10, KOISHIKAWA 4-CHOME, BUNKYO-KU |
| TOKYO, JAPAN 1128088 |
|
|
Correspondence name and address
|
| |
FAEGRE DRINKER BIDDLE & REATH LLP
|
| |
1500 K ST NW
|
| |
SUITE 1100
|
| |
WASHINGTON, DC 20005
|
Search Results as of:
05/04/2024 02:27 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
